With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...
Among patients with hereditary angioedema, baseline attack frequency and disease type did not change improvements in monthly attack rate seen with berotralstat, according to data published in Allergy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results